Maria Gaetano D.
- Country
- Italy
- Department
- N/A
Research Overview
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia
- Evaluation of High-Dose Pulse Intravenous Methylprednisolone Sodium Succinate in Patients with Complicated Fulminant Acute Myocarditis
Data & Insights
Has run more than one trial at 417 of 1153 partner sites.
Specializations
Cardiovascular Disease Management
The investigator specializes in treating complex atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease, with particular focus on preventive cardiology and lipid management.
- Non-obstructive coronary disease intervention
- Atherosclerotic plaque progression studies
- Major adverse cardiovascular events prevention
Heart Failure and Cardiomyopathy
Demonstrates expertise in treating chronic heart failure with reduced ejection fraction and various forms of inflammatory cardiomyopathy, including acute and chronic presentations.
- Advanced heart failure management
- Inflammatory cardiac conditions
- Myocarditis treatment approaches
Lipid Disorders and Prevention
Focuses on treating hypercholesterolemia and developing innovative approaches for lipid management in patients with cardiovascular risk factors.
- Cholesterol reduction therapies
- Preventive cardiology
- Cardiovascular risk management
Cardiac Rhythm Management
Specializes in managing atrial fibrillation and associated complications, with emphasis on preventing cardioembolic events and optimizing anticoagulation strategies.
- Stroke prevention in atrial fibrillation
- Systemic embolism management
- Anticoagulation therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.